Clinical Trial Update: STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer

View source ↗

Summary

A completed follow-up study evaluating men with prostate cancer on active surveillance as part of the STHLM3 AS NorDCaP trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Karolinska Institutet | Conditions: Prostate Cancer | Status: COMPLETED